BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21856392)

  • 1. Synthesis and evaluation of poly(styrene-co-maleic acid) micellar nanocarriers for the delivery of tanespimycin.
    Larson N; Greish K; Bauer H; Maeda H; Ghandehari H
    Int J Pharm; 2011 Nov; 420(1):111-7. PubMed ID: 21856392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined delivery of paclitaxel and tanespimycin via micellar nanocarriers: pharmacokinetics, efficacy and metabolomic analysis.
    Katragadda U; Fan W; Wang Y; Teng Q; Tan C
    PLoS One; 2013; 8(3):e58619. PubMed ID: 23505544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronic acid-decorated poly(lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin.
    Pradhan R; Ramasamy T; Choi JY; Kim JH; Poudel BK; Tak JW; Nukolova N; Choi HG; Yong CS; Kim JO
    Carbohydr Polym; 2015 Jun; 123():313-23. PubMed ID: 25843864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epothilone B-based 3-in-1 polymeric micelle for anticancer drug therapy.
    Shin DH; Kwon GS
    Int J Pharm; 2017 Feb; 518(1-2):307-311. PubMed ID: 28062368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro anticancer activity of docetaxel-loaded micelles based on poly(ethylene oxide)-poly(epsilon-caprolactone) block copolymers: Do nanocarrier properties have a role?
    Ostacolo L; Marra M; Ungaro F; Zappavigna S; Maglio G; Quaglia F; Abbruzzese A; Caraglia M
    J Control Release; 2010 Dec; 148(2):255-63. PubMed ID: 20816710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cremophor-free formulation for tanespimycin (17-AAG) using PEO-b-PDLLA micelles: characterization and pharmacokinetics in rats.
    Xiong MP; Yáñez JA; Kwon GS; Davies NM; Forrest ML
    J Pharm Sci; 2009 Apr; 98(4):1577-86. PubMed ID: 18752263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and evaluation of micellar nanocarriers for 17-allyamino-17-demethoxygeldanamycin (17-AAG).
    Chandran T; Katragadda U; Teng Q; Tan C
    Int J Pharm; 2010 Jun; 392(1-2):170-7. PubMed ID: 20363305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipophilic prodrugs of Hsp90 inhibitor geldanamycin for nanoencapsulation in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles.
    Forrest ML; Zhao A; Won CY; Malick AW; Kwon GS
    J Control Release; 2006 Nov; 116(2):139-49. PubMed ID: 16926059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and in vitro evaluation of 17-allyamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric mixed micelles for glioblastoma multiforme.
    Saxena V; Hussain MD
    Colloids Surf B Biointerfaces; 2013 Dec; 112():350-5. PubMed ID: 24012704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
    Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
    J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and therapeutic effect of styrene-maleic acid copolymer-conjugated pirarubicin.
    Tsukigawa K; Liao L; Nakamura H; Fang J; Greish K; Otagiri M; Maeda H
    Cancer Sci; 2015 Mar; 106(3):270-8. PubMed ID: 25529761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SMA-doxorubicin, a new polymeric micellar drug for effective targeting to solid tumours.
    Greish K; Sawa T; Fang J; Akaike T; Maeda H
    J Control Release; 2004 Jun; 97(2):219-30. PubMed ID: 15196749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo evaluation of tumor targeting styrene-maleic acid copolymer-pirarubicin micelles: Survival improvement and inhibition of liver metastases.
    Daruwalla J; Nikfarjam M; Greish K; Malcontenti-Wilson C; Muralidharan V; Christophi C; Maeda H
    Cancer Sci; 2010 Aug; 101(8):1866-74. PubMed ID: 20579075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH-sensitive polymeric cisplatin-ion complex with styrene-maleic acid copolymer exhibits tumor-selective drug delivery and antitumor activity as a result of the enhanced permeability and retention effect.
    Saisyo A; Nakamura H; Fang J; Tsukigawa K; Greish K; Furukawa H; Maeda H
    Colloids Surf B Biointerfaces; 2016 Feb; 138():128-37. PubMed ID: 26674841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-delivery of paclitaxel and tanespimycin in lipid nanoparticles enhanced anti-gastric-tumor effect in vitro and in vivo.
    Ma L; Yang D; Li Z; Zhang X; Pu L
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):904-911. PubMed ID: 29757014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid lipid nanoparticles as a novel formulation approach for tanespimycin (17-AAG) against leishmania infections: Preparation, characterization and macrophage uptake.
    Pires VC; Magalhães CP; Ferrante M; Rebouças JS; Nguewa P; Severino P; Barral A; Veras PST; Formiga FR
    Acta Trop; 2020 Nov; 211():105595. PubMed ID: 32585150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, in vitro characterization, and anti-tumor effects of novel polystyrene-poly(amide-ether-ester-imide) co-polymeric micelles for delivery of docetaxel in breast cancer in Balb/C mice.
    Varshosaz J; Enteshari S; Hassanzadeh F; Hashemi-Beni B; Minaiyan M; Mirsafaei R
    Drug Dev Ind Pharm; 2018 Jul; 44(7):1139-1157. PubMed ID: 29436875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of raloxifene-targeted poly(styrene maleic acid)-poly (amide-ether-ester-imide) co-polymeric nanomicelles loaded with docetaxel in breast cancer-bearing mice.
    Enteshari S; Varshosaz J; Minayian M; Hassanzadeh F
    Invest New Drugs; 2018 Apr; 36(2):206-216. PubMed ID: 29177974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copoly(styrene-maleic acid)-pirarubicin micelles: high tumor-targeting efficiency with little toxicity.
    Greish K; Nagamitsu A; Fang J; Maeda H
    Bioconjug Chem; 2005; 16(1):230-6. PubMed ID: 15656596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypeptide-based nanogels co-encapsulating a synergistic combination of doxorubicin with 17-AAG show potent anti-tumor activity in ErbB2-driven breast cancer models.
    Desale SS; Raja SM; Kim JO; Mohapatra B; Soni KS; Luan H; Williams SH; Bielecki TA; Feng D; Storck M; Band V; Cohen SM; Band H; Bronich TK
    J Control Release; 2015 Jun; 208():59-66. PubMed ID: 25660204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.